We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · October 20, 2021

Efficacy of Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease

JAMA Ophthalmology


Additional Info

JAMA Ophthalmology
Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical Trials
JAMA Ophthalmol 2021 Oct 07;[EPub Ahead of Print], EJ Holland, MA Jackson, E Donnenfeld, R Piccolo, A Cohen, S Barabino, M Rolando, FC Figueiredo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading